Red Herring Asia Top 100 Enterprises 2009 award for Sundia MediTech

Sundia MediTech Company, a leading pharmaceutical R&D outsourcing service company in China, is proud to announce that the company received the Red Herring Asia Top 100 Enterprises 2009 award, an award given to the top 100 private technology companies in the Asia Pacific region.

Red Herring selects the Technology Fast 100 list every year for various regions, such as North America, Europe, and Asia Pacific, to recognize the technology companies which meet the requirements of cutting-edge technology and outstanding business models. "It has been a challenging and revealing year for most companies across the globe, yet we received a very impressive list of nominations from Asia Pacific," said Alex Vieux, CEO of Red Herring. "Companies that believe in constant innovation and consistent strategy, investing in people and technology, managed to overcome these difficult times and Sundia Meditech is one of them. They will certainly thrive in the marketplace and become a formidable force in the future. "

"We are pleased to know that Sundia received such a prestigious award for its outstanding performance in a turbulent year with the global financial and economic crises. This award reflects the high quality of Sundia's services and its successful business models," Commented Ms. Cathy Yen, General Manager of AsiaVest Partners' Shanghai branch. "We made the right decision to invest in Sundia two years ago, and I am sure Sundia will emerge as one of the market leaders in the upcoming year."

Source:

Sundia MediTech Company

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024